These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25230759)

  • 1. Increased level of nucleolin confers to aggressive tumor progression and poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Guo X; Xiong L; Yu L; Li R; Wang Z; Ren B; Dong J; Li B; Wang D
    Diagn Pathol; 2014 Sep; 9():175. PubMed ID: 25230759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival.
    Guo X; Xiong L; Zou L; Sun T; Zhang J; Li H; Peng R; Zhao J
    Diagn Pathol; 2012 Aug; 7():96. PubMed ID: 22888955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
    Li B; Shao Q; Ji D; Li F; Guo X; Chen G
    Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma.
    Guo X; Xiong L; Sun T; Peng R; Zou L; Zhu H; Zhang J; Li H; Zhao J
    Diagn Pathol; 2012 Apr; 7():44. PubMed ID: 22515642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.
    Wang H; Jiang S; Zhang Y; Pan K; Xia J; Chen M
    World J Surg Oncol; 2014 Jul; 12():226. PubMed ID: 25037578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of SOX6 confers a poor prognosis in hepatocellular carcinoma.
    Guo X; Yang M; Gu H; Zhao J; Zou L
    Cancer Epidemiol; 2013 Oct; 37(5):732-6. PubMed ID: 23731550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low levels of glycoprotein 96 indicate a worse prognosis in early-stage hepatocellular carcinoma patients after hepatectomy.
    Ji F; Zhang Y; Zhu ZB; Guo Y; Shen SL; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
    Hum Pathol; 2019 Apr; 86():193-202. PubMed ID: 30529751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of lysine specific demethylase 1 predicts worse prognosis in primary hepatocellular carcinoma patients.
    Zhao ZK; Yu HF; Wang DR; Dong P; Chen L; Wu WG; Ding WJ; Liu YB
    World J Gastroenterol; 2012 Dec; 18(45):6651-6. PubMed ID: 23236241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy.
    Liu F; Zhang Y; Peng Z; Gao H; Xu L; Chen M
    J Transl Med; 2012 Jul; 10():135. PubMed ID: 22747650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma.
    Wang WY; Zhang HF; Wang L; Ma YP; Gao F; Zhang SJ; Wang LC
    Diagn Pathol; 2014 Aug; 9():160. PubMed ID: 25123453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Villin 1 is a predictive factor for the recurrence of high serum alpha-fetoprotein-associated hepatocellular carcinoma after hepatectomy.
    Xieraili M; Yasen M; Mogushi K; Obulhasim G; Mayinuer A; Aihara A; Tanaka S; Mizushima H; Tanaka H; Arii S
    Cancer Sci; 2012 Aug; 103(8):1493-501. PubMed ID: 22530999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EIF4EBP1 overexpression is associated with poor survival and disease progression in patients with hepatocellular carcinoma.
    Cha YL; Li PD; Yuan LJ; Zhang MY; Zhang YJ; Rao HL; Zhang HZ; Zheng XF; Wang HY
    PLoS One; 2015; 10(2):e0117493. PubMed ID: 25658620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of glioma-associated oncogene 2 (Gli 2) is correlated with poor prognosis in patients with hepatocellular carcinoma undergoing hepatectomy.
    Zhang D; Cao L; Li Y; Lu H; Yang X; Xue P
    World J Surg Oncol; 2013 Jan; 11():25. PubMed ID: 23356443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of snoRNA SNORA52 and Its Clinical Significance in Hepatocellular Carcinoma.
    Ding Y; Sun Z; Zhang S; Li Y; Han X; Xu Q; Zhou L; Xu H; Bai Y; Xu C; Ding H; Ge Y; Wang W
    Biomed Res Int; 2021; 2021():7020637. PubMed ID: 34195281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy.
    Chen HL; OuYang HY; Le Y; Jiang P; Tang H; Yu ZS; He MK; Tang YQ; Shi M
    Cancer Med; 2018 Nov; 7(11):5339-5350. PubMed ID: 30306706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NEMO expression in human hepatocellular carcinoma and its association with clinical outcome.
    Aigelsreiter A; Haybaeck J; Schauer S; Kiesslich T; Bettermann K; Griessbacher A; Stojakovic T; Bauernhofer T; Samonigg H; Kornprat P; Lackner C; Pichler M
    Hum Pathol; 2012 Jul; 43(7):1012-9. PubMed ID: 22176836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyskerin overexpression in human hepatocellular carcinoma is associated with advanced clinical stage and poor patient prognosis.
    Liu B; Zhang J; Huang C; Liu H
    PLoS One; 2012; 7(8):e43147. PubMed ID: 22912812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revealing the clinical significance and prognostic value of small nucleolar RNA SNORD31 in hepatocellular carcinoma.
    Ding Y; Sun Z; Zhang S; Xu Q; Zhou L; Zhou D; Li Y; Han X; Xu H; Bai Y; Xu C; Ding H; Ge Y; Wang W
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32697317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.
    Yang H; Xiong FX; Lin M; Yang Y; Nie X; Zhou RL
    J Cancer Res Clin Oncol; 2010 Feb; 136(2):275-81. PubMed ID: 19690886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.